Health ❯ Healthcare ❯ Medical Research ❯ Cancer Research

Breast Cancer

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Researchers will use the findings to design a Phase II efficacy trial planned for late 2026.

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Study Pinpoints Protein That Enables Drug-Triggered Rupture of Breast Cancer Cells

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

AI From Screening Mammograms Flags Short‑Term Risk of Interval Breast Cancers

Genetic Risk Score Flags Future Breast Cancer Risk After DCIS or LCIS

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

Meta-Analysis Reveals Opposing Breast Cancer Risks of Hormone Replacement Therapy in Women Under 55

TM3-4 Peptides Suppress Breast Cancer Growth by Targeting VIPR2 Dimers

UK Study Advocates New Breast Cancer Screening for Women with Dense Tissue